Show
Sort by
-
- Journal Article
- A1
- open access
Genome-wide association study of treatment-related toxicity two years following radiotherapy for breast cancer
-
- Journal Article
- A2
- open access
Large-scale meta–genome-wide association study reveals common genetic factors linked to radiation-induced acute toxicities across cancer types
-
Hippocampal avoidance prophylactic cranial irradiation (HA-PCI) for small cell lung cancer reduces hippocampal atrophy compared to conventional PCI
-
Treatment of oligometastatic non-small cell lung cancer : an ASTRO/ESTRO clinical practice guideline
-
- Journal Article
- A1
- open access
Comparing symptom reporting by prostate cancer patients and healthcare professionals in the international multicentre REQUITE study
-
- Journal Article
- A1
- open access
(Pre)treatment risk factors for late fatigue and fatigue trajectories following radiotherapy for breast cancer
-
- Journal Article
- A1
- open access
Comparison of prone and supine positioning for breast cancer radiotherapy using REQUITE data : dosimetry, acute and two years physician and patient-reported outcomes
-
- Journal Article
- A2
- open access
Development and optimization of a machine-learning prediction model for acute desquamation after breast radiation therapy in the multicenter REQUITE cohort
-
Use of angiotensin converting enzyme inhibitors is associated with reduced risk of late bladder toxicity following radiotherapy for prostate cancer
-
- Journal Article
- A1
- open access
Overview of health-related quality of life and toxicity of non-small cell lung cancer patients receiving curative-intent radiotherapy in a real-life setting (the REQUITE study)
-
The correlation between pre-treatment symptoms, acute and late toxicity and patient-reported health-related quality of life in non-small cell lung cancer patients : results of the REQUITE study
-
- Journal Article
- A1
- open access
Treatment time and circadian genotype interact to influence radiotherapy side-effects : a prospective European validation study using the REQUITE cohort
-
Role of radiotherapy in the management of brain metastases of NSCLC : decision criteria in clinical routine
-
Phase 3 randomized trial of prophylactic cranial irradiation with or without hippocampus avoidance in SCLC (NCT01780675)
-
- Journal Article
- A1
- open access
Development of a method for generating SNP interaction-aware polygenic risk scores for radiotherapy toxicity
-
Why did the randomized trial of prophylactic cranial irradiation with or without hippocampus avoidance in SCLC not reveal a difference?
-
- Journal Article
- A1
- open access
Reaction on the interpretation of the hippocampus avoidance prophylactic cranial irradiation trial in SCLC (NCT01780675)
-
Role of postoperative radiotherapy in the management for resected NSCLC : decision criteria in clinical routine pre- and post-LungART
-
- Journal Article
- A1
- open access
Stereotactic ablative body radiotherapy (SABR) combined with immunotherapy (L19-IL2) versus standard of care in stage IV NSCLC patients, ImmunoSABR : a multicentre, randomised controlled open-label phase II trial
-
- Journal Article
- A1
- open access
External validation of a predictive model for acute skin radiation toxicity in the REQUITE Breast Cohort
-
- Journal Article
- A1
- open access
A deep learning approach validates genetic risk factors for late toxicity after prostate cancer radiotherapy in a REQUITE Multi-National Cohort
-
ESTRO ACROP guidelines for target volume definition in the thoracic radiation treatment of small cell lung cancer
-
Inter-observer variability in target delineation increases during adaptive treatment of head-and-neck and lung cancer
-
Definition of synchronous oligometastatic non–small cell lung cancer : a consensus report
-
- Journal Article
- A1
- open access
REQUITE: A prospective multicentre cohort study of patients undergoing radiotherapy for breast, lung or prostate cancer
-
ESTRO ACROP guidelines for target volume definition in the treatment of locally advanced non-small cell lung cancer
-
Individual patient data meta-analysis shows a significant association between the ATM rs1801516 SNP and toxicity after radiotherapy in 5456 breast and prostate cancer patients
-
PET imaging of zirconium-89 labelled cetuximab : a phase I trial in patients with head and neck and lung cancer
-
- Journal Article
- A1
- open access
Molecular and translational classifications of DAMPs in immunogenic cell death
-
- Journal Article
- A1
- open access
Fatal bilateral pneumonitis after locoregional thoracic chemoradiation in a transplanted patient under immunosuppressive therapy
-
Radiogenomics: radiobiology enters the era of big data and team science
-
Inducers of immunogenic cancer cell death
-
Cardiac comorbidity is an independent risk factor for radiation-induced lung toxicity in lung cancer patients
-
Quantification of radiation-induced lung damage with CT scans: the possible benefit for radiogenomics
-
Radiation-induced oesophagitis in lung cancer patients: is susceptibility for neutropenia a risk factor?
-
No association between TGF-β1 polymorphisms and radiation-induced lung toxicity in a European cohort of lung cancer patients
-
Development of a multicomponent prediction model for acute esophagitis in lung cancer patients receiving chemoradiotherapy
-
Small-cell lung cancer
-
Design of and technical challenges involved in a framework for multicentric radiotherapy treatment planning studies
-
A systematic methodology review of phase I radiation dose escalation trials
-
Establishment of a radiogenomics consortium
-
Development, external validation and clinical usefulness of a practical prediction model for radiation-induced dysphagia in lung cancer patients
-
Complete metabolic remission of an irresectable mediastinal solitary fibrous tumor with concurrent chemo-radiation
-
Dose-intensified accelerated vindesine-ifosfamide-cisplatin (VIP) chemotherapy followed by high-dose accelerated hyperfractionated radiotherapy in patients with pathologically proven stage IIIB non-small cell lung cancer: a feasibility study